Literature DB >> 21272054

Understanding the time course of pharmacological effect: a PKPD approach.

Daniel F B Wright1, Helen R Winter, Stephen B Duffull.   

Abstract

The key concepts that underpin the choice of drug and dosing regimen are an understanding of the drugs' effectiveness, the potential for adverse effects, and the expected time course over which both desired and adverse effects are likely to occur. Research in clinical pharmacology should therefore address three fundamental questions: (1) What is the magnitude of drug effects (beneficial or adverse) from a given dose? (2) How quickly will any given effects occur? (3) How long will these effects last? Under steady-state conditions, only the magnitude of drug effects can be examined. This requires researchers to consider non-steady-state conditions, which require more complex models and an understanding of the mechanisms that drive the time course of drug effect. The aim of this review is to provide a conceptual framework for understanding the time course of drug effects using pharmacokinetic-pharmacodynamic models. Key examples will illustrate how this can inform the optimal use of drugs in the clinic.
© 2011 The Authors. British Journal of Clinical Pharmacology © 2011 The British Pharmacological Society.

Mesh:

Substances:

Year:  2011        PMID: 21272054      PMCID: PMC3099368          DOI: 10.1111/j.1365-2125.2011.03925.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  35 in total

Review 1.  Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors.

Authors:  C A Stedman; M L Barclay
Journal:  Aliment Pharmacol Ther       Date:  2000-08       Impact factor: 8.171

2.  Building population pharmacokinetic--pharmacodynamic models. I. Models for covariate effects.

Authors:  J W Mandema; D Verotta; L B Sheiner
Journal:  J Pharmacokinet Biopharm       Date:  1992-10

Review 3.  Population pharmacokinetics I: background, concepts, and models.

Authors:  Ene I Ette; Paul J Williams
Journal:  Ann Pharmacother       Date:  2004-08-24       Impact factor: 3.154

Review 4.  Interpreting population pharmacokinetic-pharmacodynamic analyses - a clinical viewpoint.

Authors:  Stephen B Duffull; Daniel F B Wright; Helen R Winter
Journal:  Br J Clin Pharmacol       Date:  2011-06       Impact factor: 4.335

5.  Comparison of four basic models of indirect pharmacodynamic responses.

Authors:  N L Dayneka; V Garg; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1993-08

Review 6.  Kinetics of pharmacologic response.

Authors:  N H Holford; L B Sheiner
Journal:  Pharmacol Ther       Date:  1982       Impact factor: 12.310

Review 7.  Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models.

Authors:  N H Holford; L B Sheiner
Journal:  Clin Pharmacokinet       Date:  1981 Nov-Dec       Impact factor: 6.447

8.  Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine.

Authors:  L B Sheiner; D R Stanski; S Vozeh; R D Miller; J Ham
Journal:  Clin Pharmacol Ther       Date:  1979-03       Impact factor: 6.875

9.  Fractionation of low molecular weight heparin species and their interaction with antithrombin.

Authors:  D Beeler; R Rosenberg; R Jordan
Journal:  J Biol Chem       Date:  1979-04-25       Impact factor: 5.157

10.  Intravenously administered digoxin in patients with acute atrial fibrillation: a population pharmacokinetic/pharmacodynamic analysis based on the Digitalis in Acute Atrial Fibrillation trial.

Authors:  Björn Hornestam; Markus Jerling; Mats O Karlsson; Peter Held
Journal:  Eur J Clin Pharmacol       Date:  2003-02-19       Impact factor: 2.953

View more
  27 in total

Review 1.  Interpreting population pharmacokinetic-pharmacodynamic analyses - a clinical viewpoint.

Authors:  Stephen B Duffull; Daniel F B Wright; Helen R Winter
Journal:  Br J Clin Pharmacol       Date:  2011-06       Impact factor: 4.335

2.  Effects of idazoxan on alcohol pharmacokinetics and intoxication: a preliminary human laboratory study.

Authors:  Carolina L Haass-Koffler; Lorenzo Leggio; Dena Davidson; Robert M Swift
Journal:  Alcohol Clin Exp Res       Date:  2015-04       Impact factor: 3.455

Review 3.  What do we learn from repeated population analyses?

Authors:  Stephen B Duffull; Daniel F B Wright
Journal:  Br J Clin Pharmacol       Date:  2015-01       Impact factor: 4.335

4.  Preclinical Evaluation of Acylhydrazone SB-AF-1002 as a Novel Broad-Spectrum Antifungal Agent.

Authors:  Cristina Lazzarini; Krupanandan Haranahalli; J Brian McCarthy; John Mallamo; Iwao Ojima; Maurizio Del Poeta
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

5.  Pharmacodynamics of Tebipenem: New Options for Oral Treatment of Multidrug-Resistant Gram-Negative Infections.

Authors:  Laura McEntee; Adam Johnson; Nicola Farrington; Jennifer Unsworth; Aaron Dane; Akash Jain; Nicole Cotroneo; Ian Critchley; David Melnick; Thomas Parr; Paul G Ambrose; Shampa Das; William Hope
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

6.  Pharmacokinetic-pharmacodynamic modeling of the effect of varenicline on nicotine craving in adult smokers.

Authors:  Patanjali Ravva; Marc R Gastonguay; Hélène M Faessel; Theodore C Lee; Raymond Niaura
Journal:  Nicotine Tob Res       Date:  2014-08-21       Impact factor: 4.244

7.  An Algorithm and R Program for Fitting and Simulation of Pharmacokinetic and Pharmacodynamic Data.

Authors:  Jijie Li; Kewei Yan; Lisha Hou; Xudong Du; Ping Zhu; Li Zheng; Cairong Zhu
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-06       Impact factor: 2.441

Review 8.  Altering ethanol pharmacokinetics to treat alcohol use disorder: Can you teach an old dog new tricks?

Authors:  Carolina L Haass-Koffler; Fatemeh Akhlaghi; Robert M Swift; Lorenzo Leggio
Journal:  J Psychopharmacol       Date:  2017-01-16       Impact factor: 4.153

9.  The clinical utility of pharmacometric models.

Authors:  Shaun S Kumar; Eman Biltaji; Robert Bies; Catherine M Sherwin
Journal:  Br J Clin Pharmacol       Date:  2018-05-02       Impact factor: 4.335

10.  Quantitative Systems Pharmacology: A Framework for Context.

Authors:  Ioannis P Androulakis
Journal:  Curr Pharmacol Rep       Date:  2016-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.